Bcl-XL and Bcl-2 Expression in Bilharzial Squamous Cell Carcinoma of the Urinary Bladder: Which Protein Is Prognostic?

Urology

Volumn 72, Issue 2, 2008, Pages 374-378

  Hameed, Diaa A ^a   Abdel Raheem, Ahmad M ^c   Mosad, Eman ^c   Hammouda, Hisham M ^a   Kamel, Nermen A ^b   Abdel Aziz, Mohammad Atef ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b Assiut University   (Egypt)

^c ASSIUT UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL XL;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHISTOSOMA; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; BCL-X PROTEIN; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 48349109825     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.12.063     Document Type: Article

References (21)

1. World Health Organization. The control of schistosomiasis: report of a WHO Expert Committee-public health impact of schistosomiasis: disease and mortality. Bull WHO 71 (1993) 657-662
2. Ghoneim M.A. Bilharziasis of the genitourinary tract. BJU Int 89 suppl 1 (2002) 22-30
3. Zangemeister-Wittke U., Leech S.H., Olie R.A., et al. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells. Clin Cancer Res 6 (2000) 2547-2555
4. Tyurina Y.Y., Tyurin V.A., Carta G., et al. Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells. Archiv Biochem Biophys 344 (1997) 413-423
5. Baffy G., Miyashita T., Williamson J., et al. Apoptosis is induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line, is associated with repartitioning of intracellular calcium, and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 268 (1993) 6511-6519
6. van der Heiden G., Chandel N., Williamson E., et al. Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91 (1997) 627-637
7. Fukuda K., and Yamamoto M. Acquisition of resistance to apoptosis and necrosis by Bcl-xL over-expression in rat hepatoma McA-RH8994 cells. J Gastroenterol Hepatol 14 (1999) 682-690
8. Haitel A., Posch B., El-Baz M., et al. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factors and c-erbB-2. J Urol 165 (2001) 1481-1487
9. Janumyan Y., Sansam C., Chattopadhyay A., et al. Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J 22 (2003) 5459-5470
10. Cooke P.W., James N.D., Ganesan R., et al. Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy. BJU Int 85 (2000) 829-835
11. Touloupidis S., Fatles G., Kalaitzis C., et al. The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder. Int Urol Nephrol 38 (2006) 231-236
12. Uchida T., Minei S., Gao J., et al. Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder. Oncol Rep 9 (2002) 253-259
13. Tricker A.R., Mostafa M.H., Spiegelhalder B., et al. Urinary excretion of nitrate, nitrite and N-nitroso compounds in schistosomiasis and bilharzial bladder cancer patients. Carcinogenesis 10 (1989) 547-552
14. Higgy N.A., Verma A.K., Erturk E., et al. Augmentation of N-butyl-N-(4-hydroxybutyl) nitrosamine (BHBN) bladder carcinogenicity in Fischer 344 female rats by urinary infection. Proc Annu Meet Am Assoc Cancer Res 26 (1985) 118-134
15. Gazzaniga P., Gradilone A., Giuliani L., et al. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol 14 (2003) 85-90
16. Korkolopoulou P., Lazaris A., Konstantinidou A.E., et al. Differential expression of Bcl-2 family proteins in bladder carcinomas: relationship with apoptotic rate and survival. Eur Urol 41 (2002) 274-283
17. Chang B.S., Minn A.J., Muchmore S.W., et al. Identification of a novel regulatory domain in Bcl-XL and Bcl-2. EMBO J 16 (1997) 968-977
18. Swellam M., Abd-Elmaksoud N., Halim M.H., et al. Incidence of Bcl-2 expression in bladder cancer: relation to schistosomiasis. Clin Biochem 37 (2004) 798-802
19. Badr K.M., Nolen J.D., Derose P.B., et al. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1). Hum Pathol 35 (2004) 184-189
20. Brady H., Gil-Gomez G., Kirberg J., et al. BAX alpha perturbs T cell development and affects cell cycle entry of T cells. EMBO J 15 (1996) 6991-7001
21. Zamzami N., Brenner C., Marzo I., et al. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16 (1998) 2265-2282